Research & Education

Biology and Treatment of Thoracic Neuroendocrine Tumors

Wednesday, June 21, 2017 at 9:00PM EDT

This live session of IASLC Lung Cancer Grand Rounds features Dr. Gregory Riely. In this program Dr. Riely will review recent advances in our understanding of the biology and treatment of thoracic neuroendocrine tumors.

Immunotherapy: A New Standard of Care in NSCLC

Monday, May 15, 2017 - 6:00PM CEST (Central European Summer Time) - Recording Available

Cancer immunotherapy is emerging as one of the most promising areas of cancer research and treatment.Overall, the goal of cancer immunotherapy is to stimulate a patient's immune system to recognize cancer cells as foreign and attack them.

Locally Advanced NSCLC: Where Are We, Where Do We Go From Here?

Tuesday, May 9, 2017 at 9:00PM EDT - Recording Available

This webinar will provide an updated overview of current standard therapies for stage III NSCLC. It will also review the most recent data and current trials likely to impact standards of care.

Is There An Oligometastatic State in NSCLC?

Wednesday, May 3, 2017,11:00AM EDT / 9:00AM MDT - Recording Available

This webinar will feature two presentations and will be followed by a question and answer session.

NSCLC: Management of Brain Metastases

Wednesday, April 19, 2017 at 9:00PM EDT - Recording Available

In this program, we will cover: the incidence and epidemiology of brain metastases in NSCLC; its prognostic implications; current management, including surgical, radiation and systemic options.

Side Effects of Immune Checkpoint Inhibitors

Tuesday, March 21, 2017 at 9:00PM EST - Recording Available

With the integration of immunotherapy in the treatment of non-small cell lung cancer, recognition of potential side effects associated with immunotherapy and management of symptoms are essential components of overall care.

Management of Squamous Cell Carcinoma of the Lung

Thursday March 16, 2017 at 9:00PM EST - Recording Available

In this program we will examine the evolving therapeutic landscape for the treatment of squamous cell non-small cell lung cancer. The introduction of immune checkpoint inhibitors into treatment algorithms is the primary catalyst of new therapeutic options.

Immunotherapy for NSCLC: What's Next?

February 7, 2017 at 9:00PM EST - Recording Available

This presentation will provide an update on how immunotherapy has rapidly integrated into standard 1st and 2nd-Line and beyond treatment settings.

IASLC 17th World Conference on Lung Cancer: Main Highlights

January 26, 2017 at 9:00PM EST - Recording Available

In this live webinar Dr. Taofeek K. Owonikoko and Dr. Ramaswamy Govindan will discuss key abstracts, presentations, and developments reported in Vienna, Austria during the recent (December 4-7, 2016) 17th World Conference on Lung Cancer (WCLC).

Emerging Therapy Options in Immunotherapy for NSCLC

December 20, 2016 at 9:00PM EST - Recording Available

Immunotherapy is now a standard option for treatment of patients with non-small cell lung cancer and has been shown to improve survival compared to chemotherapy in a subset of patients. This

Pages